Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 5/2005

01-05-2005 | Brief Report

Sirolimus rescue of renal failure in children after combined liver-kidney transplantation

Authors: Udo Vester, Birgitta Kranz, Silvio Nadalin, Andreas Paul, Jan Becker, Peter F. Hoyer

Published in: Pediatric Nephrology | Issue 5/2005

Login to get access

Abstract

Background: Calcineurin inhibitors (CNI) are the main immunosuppressive drugs in solid organ transplantation. However, their use is hampered by side effects like nephrotoxicity. We report an exceptional experience with three children treated with sirolimus after combined liver and kidney transplantation with prolonged renal failure and CNI-associated nephrotoxicity. Patients and results: Two girls experienced prolonged renal graft failure after combined liver-kidney transplantation for 11 and 12 weeks. Repeated biopsies did not show any rejection but did exhibit tubular damage and acute CNI-toxicity. A boy with hyperoxaluria after liver and (a third) renal transplantation experienced acute renal graft failure after an early steroid-resistant rejection. All children were switched to sirolimus-based immunosuppression and cessation of CNI therapy, which was followed by rapid improvement of renal function. Rejection of liver or kidney did not occur after CNI withdrawal. Sirolimus was commenced with 3 mg/m2/day in two doses and resulted in reasonable drug exposure. However, drug monitoring was required to adjust sirolimus dosage. Summary: Prolonged renal failure after transplantation with severe CNI toxicity may be salvaged successfully with sirolimus-based immunosuppression.
Literature
1.
Seikaly M, Ho PL, Emmett L, Tejani A (2001) The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 5:215–231CrossRefPubMed
2.
Burdmann EA, Andoh TF, Yu L, Bennett WM (2003) Cyclosporine nephrotoxicity. Semin Nephrol 23:465–476CrossRef
3.
Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kd s6 protein kinases. Cell 69:1227–1236CrossRef
4.
Kahan BD (for the Rapamune US Study Group)(2000) Efficacy of sirolimus compared to azathioprin for reduction of acute renal allograft rejection: a randomized multicentre study. Lancet 356:194–202CrossRef
5.
McAlister VC Gao Z, Peltekian K, Domingues J, Mahalati K, MacDonald AS (2000). Sirolimus-tacrolimus combination immunosuppression. Lancet 355:376–377CrossRef
6.
Flechner SM, Galdfarb D, Modlin C, Feng J, Krishnamurthi V, Mastroianni B, Savas K, Cook DJ, Novick AC (2002) Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 74:1070–1076CrossRef
7.
Trotter JF (2003) Sirolimus in liver transplantation. Transplant Proc 35(Suppl):S193–S200CrossRef
8.
Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF (for the Rapamune Maintenance Regimen Trial)(2004) Long-term benefit with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15:809–817CrossRef
9.
Egidi MF, Cowan PA, Naseer A, Gaber AO (2003). Conversion to sirolimus in solid organ transplantation: a single center experience. Transplant Proc 35(3 Suppl):S131–S137CrossRef
10.
Citterlo F, Scata MC, Violi P, Romagnoli J, Pozzetto U, Nani G, Castagneto M (2003) Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients. Transplant Proc 35:1292–1294CrossRef
11.
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
12.
Fritsche L, Budde K, Dragun D, Einecke G, Diekmann F, Neumayer HH (2004) Testosterone concentrations and sirolimus in male renal transplant patients. Am J Transplant 4:130–131CrossRef
13.
Ettenger RB, Grimm EM (2001) Safety and efficacy of TOR inhibitor in pediatric renal transplant recipients. Am J Kid Dis 38(4 Suppl 2):S22–S28
14.
Sindhi R, Webber S, Venkataramanan R, McGhee W, Phillips S, Smith A, Baird C, Iurlano K, Mazariegos G, Cooperstone B, Holt DW, Zeevi A, Fung JJ, Reyes J (2001) Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 72:851–855CrossRef
15.
Schachter AD, Meyers KE, Spaneas LD, Palmer JA, Salmanullah M, Baluarte J, Brayman KL, Harmon WE (2004) Short sirolimus half-life in pediatric transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant 8:171–177CrossRef
16.
Sindhi R (2003) Sirolimus in pediatric transplant recipients. Transplant Proc 35(Suppl):S113–S114CrossRef
17.
Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP (2004) Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr Transplant 8:362–366CrossRef
18.
Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, Ancelet D, Soulillou JP (1998) Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 54:972–978CrossRef
19.
Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G (1990) Kidney transplantation in primary oxalosis: data from the EDTA registry. Nephrol Dial Transplant 5:332–336
20.
Stallone G, Di Paolo S, Schena A, Infante B, Battaglia M, Ditonno P, Gesualdo L, Grandaliano G, Schena FP (2004) Addition of sirolimus to cyclosporine delays recovery from delayed graft function but does not affect 1-year graft function. J Am Soc Nephrol 15:228–233CrossRef
21.
Lieberthal W, Fuhro R, Andry CC, rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:693–706
22.
Podder H, Stepkowski SM, Napoli KL, Clark J, Verani RR, Chou TC, Kahan BD (2001) Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol 12:1059–1071
23.
Schubert M, Venkataramanan R, Holt DW, Shaw LM, McGhee W, Reyes J, Webber S, Sindhi R (2004) Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. Am J Transplant 4:767–773
Metadata
Title
Sirolimus rescue of renal failure in children after combined liver-kidney transplantation
Authors
Udo Vester
Birgitta Kranz
Silvio Nadalin
Andreas Paul
Jan Becker
Peter F. Hoyer
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 5/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1733-4

Other articles of this Issue 5/2005

Pediatric Nephrology 5/2005 Go to the issue

Book Review

Thomas J.A. Lehman: It’s not just growing pains: a guide to childhood muscle, bone, and joint pain, rheumatic diseases, and the latest treatments

Letter to the Editors

Blood pressure in the long-term follow-up of children with haemolytic uremic syndrome

Letter to the Editors

Hypocomplementaemia and septicaemia

Original Article

Renal involvement in Down syndrome

Original Article

Serum and urine leptin concentration in children with nephrotic syndrome

Review

A mechanistic approach to inherited polycystic kidney disease